Aytu BioScience, Inc. Recorded Big Gain

Aytu BioScience, Inc. (AYTU:NASDAQ) jumped higher at $0.69, a gain of 33.6%. On Thu, Jun 30, 2022, AYTU:NASDAQ touched a New 2-Week High of $0.69. The stock appeared on our News Catalysts scanner on Wed, Jun 29, 2022 at 08:36 AM in the 'INVESTOR UPDATE' category. From Thu, Jun 16, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days

About Aytu BioScience, Inc. (AYTU:NASDAQ)

Aytu BioScience Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved nasal formulation of testosterone, ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, Cefaclor, Karbinal ER, and Poly-Vi-Flor and Tri-Vi-Flor.